ARTICLE
14 October 2020

Healthcare Companies Cashing In On Financing Vehicle Boom

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
John Washlick, shareholder in the firm's Healthcare section, is quoted in the Modern Healthcare article, "Healthcare companies cashing in on financing vehicle boom."
United States Food, Drugs, Healthcare, Life Sciences

John Washlick, shareholder in the firm's Healthcare section, is quoted in the Modern Healthcare article, "Healthcare companies cashing in on financing vehicle boom."

Investors tend to feel more secure putting their money in SPACs because SPACs are required to spend the money raised through their IPOs within two years or return it to their investors, said John Washlick, a shareholder with Buchanan, Ingersoll & Rooney. They're also limited in how they can spend the money.

That said, investors still need to research the executives behind any SPAC they consider buying into, Washlick said. Investors should make sure those involved have good track records, especially in the industry they're targeting.

"Raising money is one thing, but what are you going to do with it?" he said. "How are you going to spend it responsibly so that my $10 becomes more than $10? I'm looking for a return on it, not to give it back."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More